- Home
- Publications
- Publication Search
- Publication Details
Title
The new drug phenomenon
Authors
Keywords
-
Journal
Drug Testing and Analysis
Volume 6, Issue 7-8, Pages 587-597
Publisher
Wiley
Online
2014-07-03
DOI
10.1002/dta.1686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The (mis)use of psychoactive medicines: getting the balance right in complex systems
- (2014) Paul Griffiths et al. ADDICTION
- The rise of new psychoactive substance use in Australia
- (2014) Lucy Burns et al. Drug Testing and Analysis
- New psychoactive substances legislation in Ireland - Perspectives from academia
- (2014) Pierce V. Kavanagh et al. Drug Testing and Analysis
- The syntheses, characterization andin vitrometabolism of nitracaine, methoxypiperamide and mephtetramine
- (2014) John D. Power et al. Drug Testing and Analysis
- Using poisons information service data to assess the acute harms associated with novel psychoactive substances
- (2014) D. M. Wood et al. Drug Testing and Analysis
- Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions
- (2014) Marie Claire Van Hout Drug Testing and Analysis
- Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology
- (2014) Kayla N. Ellefsen et al. Drug Testing and Analysis
- New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
- (2014) Claudio Vidal Giné et al. Drug Testing and Analysis
- The interim regulated legal market for NPS (‘legal high’) products in New Zealand: The impact of new retail restrictions and product licensing
- (2014) Chris Wilkins Drug Testing and Analysis
- Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective
- (2014) Anna Duffert Drug Testing and Analysis
- Cathinones derivatives-related deaths as exemplified by two fatal cases involving methcathinone with 4-methylmethcathinone and 4-methylethcathinone
- (2014) Sebastian Rojek et al. Drug Testing and Analysis
- Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones
- (2014) Anna Péterfi et al. Drug Testing and Analysis
- Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia
- (2014) Lucy Burns et al. Drug Testing and Analysis
- Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics
- (2014) Bjoern Moosmann et al. Drug Testing and Analysis
- From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs
- (2014) Hamilton Morris et al. Drug Testing and Analysis
- Characterization of a novel and potentially lethal designer drug(±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or ‘Serotoni’)
- (2014) Simon D. Brandt et al. Drug Testing and Analysis
- Deaths from “legal highs”: a problem of definitions
- (2014) Leslie A King et al. LANCET
- Legal highs: a problem of definitions? – Authors' reply
- (2014) Leslie A King et al. LANCET
- Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement?
- (2014) M. Evans-Brown et al. BMJ-British Medical Journal
- Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age
- (2013) Paul Griffiths et al. ADDICTION
- Characterization of the pyrolysis products of methiopropamine
- (2013) Emily D. Bouso et al. Drug Testing and Analysis
- Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan
- (2013) Ruri Kikura-Hanajiri et al. Drug Testing and Analysis
- Cross-reactivity of designer drugs, including cathinone derivatives, in commercial enzyme-linked immunosorbent assays
- (2013) Madeleine J. Swortwood et al. Drug Testing and Analysis
- An investigation of the stability of emerging new psychoactive substances
- (2013) Yan Ni Annie Soh et al. Drug Testing and Analysis
- Characterization of synthetic routes to ‘Bromo-DragonFLY’ and benzodifuranyl isopropylamine homologues utilizing ketone intermediates. Part 1: Synthesis of ketone precursors
- (2013) Richard E. O'Connor et al. Drug Testing and Analysis
- Drug laws and the 'derivative' problem
- (2013) Leslie A. King et al. Drug Testing and Analysis
- 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO)
- (2013) Tomás Herraiz et al. Drug Testing and Analysis
- Analysis of 1,3 dimethylamylamine concentrations inGeraniaceae, geranium oil and dietary supplements
- (2013) Krista G. Austin et al. Drug Testing and Analysis
- A methamphetamine analog (N,α-diethyl-phenylethylamine) identified in a mainstream dietary supplement
- (2013) Pieter A. Cohen et al. Drug Testing and Analysis
- Thein vivoandin vitrometabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn
- (2013) Markus R. Meyer et al. Drug Testing and Analysis
- DART-MS for rapid, preliminary screening of urine for DMAA
- (2013) Ashton D. Lesiak et al. Drug Testing and Analysis
- Predicting the activity and toxicity of new psychoactive substances: a pharmaceutical industry perspective
- (2013) Andrew G. Leach Drug Testing and Analysis
- Study of collision-induced dissociation of electrospray-generated protonated cathinones
- (2013) Emilia Fornal Drug Testing and Analysis
- Optimization, validation, and the application of liquid chromatography-tandem mass spectrometry for the analysis of new drugs of abuse in wastewater
- (2013) Alexander L. N. van Nuijs et al. Drug Testing and Analysis
- Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues
- (2013) Jason Wallach et al. Drug Testing and Analysis
- Discrimination of cathinone regioisomers, sold as ‘legal highs’, by Raman spectroscopy
- (2013) R. Christie et al. Drug Testing and Analysis
- New phenethylamines in Europe
- (2013) L. A. King Drug Testing and Analysis
- Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication
- (2013) Justin L. Poklis et al. Drug Testing and Analysis
- Identification of (2-aminopropyl)indole positional isomers in forensic samples
- (2013) Kenneth R. Scott et al. Drug Testing and Analysis
- New victims of current drug laws
- (2013) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Effects of Schedule I drug laws on neuroscience research and treatment innovation
- (2013) David J. Nutt et al. NATURE REVIEWS NEUROSCIENCE
- Pharmacological approaches to methamphetamine dependence: a focused review
- (2010) Laurent Karila et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Dual dopamine/serotonin releasers: Potential treatment agents for stimulant addiction.
- (2008) Richard B. Rothman et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now